In brief: Meningococcal prophylaxis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D008910:Minnesota; D009345:Neisseria meningitidis / Q000187:drug effects*; D009658:North Dakota; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines; D002939:Ciprofloxacin; D002443:Ceftriaxone; D017963:Azithromycin; D012293:Rifampin